Development of a National Public Pharmaceutical Research and Development Institute

, &
Journal of Law, Medicine and Ethics 48 (1):225-227 (2020)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1177/1073110520917023

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The development of chemistry at the National Medical Institute, 1888-1915.Liliana Schifter & Patricia Aceves Pastrana - 2015 - Circumscribere: International Journal for the History of Science 16:41-56.
Five Un‐Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
Pharmaceutical companies and access to medicines – social integration and ethical CSR resolution of a global public choice problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
Bioethics in the Oversight of Clinical Research: Institutional Review Boards and Data and Safety Monitoring Boards.Christine Grady - 2019 - Kennedy Institute of Ethics Journal 29 (1):33-49.
Institutional mistrust in the organization of pharmaceutical clinical trials.Jill A. Fisher - 2008 - Medicine, Health Care and Philosophy 11 (4):403-413.
Using Research to Enhance Staff Development a Collaboration Between a State Education Agency and an Independent Research Organization.Joseph B. Rappa, Patricia P. Brown, Tdr Associates, Massachusetts & National Institute of Education S.) - 1983 - Tdr Associates, Inc. Massachusetts Dept. Of Education.
Conflicts of interest in drug development: The practices of merck & co., inc.Laurence J. Hirsch - 2002 - Science and Engineering Ethics 8 (3):429-442.
Antagonistic Synergy: Process and Paradox in the Development of New Agricultural Antimicrobial Regulations. [REVIEW]Wesley R. Dean & H. Morgan Scott - 2005 - Agriculture and Human Values 22 (4):479-489.
Institutionalizing Dissent: A Proposal for an Adversarial System of Pharmaceutical Research.Justin Biddle - 2013 - Kennedy Institute of Ethics Journal 23 (4):325-353.
Human development index as a measure of human development.Bojana Radovanovic - 2011 - Filozofija I Društvo 22 (3):193-208.
Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases.Michael Kremer & Rachel Glennerster - 2005 - Ethics and International Affairs 19 (3).
Private-sector research ethics: Marketing or good conflicts management? The 2005 John J. Conley lecture on medical ethics. [REVIEW]Rebecca Dresser - 2006 - Theoretical Medicine and Bioethics 27 (2):115-139.
Inventions, patents and commercial development from governmentally financed research in Great Britain: The origins of the National Research Development Corporation. [REVIEW]S. T. Keith - 1981 - Minerva 19 (1):92-122.
Conflict of interest as seen from a researcher’s perspective.Arrigo Schieppati, Norberto Perico & Giuseppe Remuzzi - 2002 - Science and Engineering Ethics 8 (3):337-342.
Using Patent Data to Assess the Value of Pharmaceutical Innovation.Aaron S. Kesselheim & Jerry Avorn - 2009 - Journal of Law, Medicine and Ethics 37 (2):176-183.

Analytics

Added to PP
2020-04-29

Downloads
11 (#1,120,716)

6 months
5 (#632,346)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references